Orio Therapeutics engineers protein therapeutics with built-in delivery mechanisms to achieve controlled localization at the injection site. This approach enhances efficacy, reduces required dosage, and minimizes side effects for regenerative medicine applications. Their initial focus is on cardiac repair therapies that limit fibrosis and preserve function after myocardial infarction.
Funding
$720K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many protein-based therapeutics in regenerative medicine suffer from limited efficacy due to uncontrolled drug delivery, leading to diffusion away from the injection site, increased side effects, and the need for higher dosages. This is particularly problematic in regenerative medicine, where localized action is crucial for tissue repair.
Solution
Orio Therapeutics engineers therapeutic proteins with enhanced localization properties, ensuring they remain at the injection site for improved efficacy and reduced dosage. By modifying proteins to incorporate a built-in delivery system, Orio Therapeutics achieves precise control over drug delivery, addressing the limitations of conventional protein therapeutics. This targeted approach aims to improve therapeutic outcomes while minimizing off-target effects and reducing overall treatment costs. The technology's adaptability allows for the improvement of various protein therapeutics that would benefit from localized delivery.
Target Audience
The primary target audience includes patients with conditions requiring regenerative medicine, with an initial focus on those who have experienced myocardial infarction, as well as pharmaceutical companies developing protein-based therapeutics.
Features
- Protein modification technology for enhanced localization at the injection site
- Controlled drug delivery system to prevent diffusion and maintain therapeutic concentration
- Adaptable system applicable to a wide range of protein therapeutics
- Potential for reduced dosage and decreased side effects compared to traditional methods
- Focus on regenerative medicine applications, particularly myocardial infarction
- Development of a molecule to protect cardiac muscle, reduce fibrosis, and preserve cardiac function after a heart attack